A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
2016 ◽
2008 ◽
Vol 17
(3)
◽
pp. 103-113
◽
2015 ◽
Vol 43
(7)
◽
pp. 524-533.e1
◽
2018 ◽
Vol 28
(3)
◽
pp. 147-153